HTA - Algorithm or process?: Comment on “Expanded HTA: Enhancing fairness and legitimacy”

International Journal of Health Policy and Management

Volumn 5, Issue 8, 2016, Pages 501-505

  Culyer, Anthony J ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Deliberation; Economic evaluation; Equity; Extended cost effectiveness; HTA processes; Quality Adjusted Life Year (QALY) algorithm; Reference case

Indexed keywords

ALGORITHM; BIOMEDICAL TECHNOLOGY ASSESSMENT; COST BENEFIT ANALYSIS; DECISION MAKING; DECISION SUPPORT SYSTEM; HEALTH CARE POLICY; HUMAN; MEDICAL TECHNOLOGY; MORALITY; SOCIAL BEHAVIOR;

ALGORITHMS; BIOMEDICAL TECHNOLOGY; COST-BENEFIT ANALYSIS; DECISION MAKING; DECISION SUPPORT TECHNIQUES; HEALTH POLICY; HUMANS; MORALS; SOCIAL RESPONSIBILITY; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 85002050627     PISSN: None     EISSN: 23225939     Source Type: Journal    
DOI: 10.15171/ijhpm.2016.59     Document Type: Article

References (30)

1. Office of Technology Assessment. Development of Medical Technology: Opportunities for Assessment. Washington DC: US Government Printing Office; 1976.
2. Banta D. The development of health technology assessment. Health Policy. 2003; 63: 121-132.
3. Daniels N, Porteny T, Urrutia J [correction of Urritia J]. Expanded HTA: enhancing fairness and legitimacy [published correction appears in Int J Health Policy Manag. 2016; 5(5): 347]. Int J Health Policy Manag. 2016; 5(1): 1-3. doi: 10.15171/ijhpm.2015.187
4. Culyer AJ, Podhisita C, Santatiwongchai B. A Star in the East: A Short History of HITAP. Bangkok: Health Intervention and Technology Assessment Program; 2016.
5. Culyer AJ. The Dictionary of Health Economics. 3rd ed. Cheltenham: Edward Elgar; 2014.
6. Hoffman BM. Toward a procedure for integrating moral issues in health technology assessment. Int J Technol Assess Health Care. 2005; 21(3): 312-318.
7. Hofmann BM. Why ethics should be part of health technology assessment. Int J Technol Assess Health Care. 2008; 24: 423-429. doi: 10.1017/S0266462308080550
8. Hoffman BM. Why not integrate ethics in HTA: identification and assessment of the reasons. GMS Health Technol Assess. 2014; 10: Doc04. doi: 10.3205/hta000120.
9. Daniels N, Sabin J. The ethics of accountability in managed care reform. Health Affairs. 1998; 17: 50-64.
10. Brouwer WB, Culyer AJ, Job N, van Exel A, Rutten FF. Welfarism vs. extra-welfarism. J Health Econ. 2008; 27: 325-338. Reprinted in Cookson R, Claxton K, eds. The Humble Economist: Tony Culyer on Health, Health Care and Social Decision Making. London: Office of Health Economics; 2012: 67-78.
11. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
12. National Institute for Health and Care Excellence. Guide to the Methods of Technology Appraisal. London: NICE; 2013.
13. Bill and Melinda Gates Foundation Methods for Economic Evaluation Project (MEEP). Final Report and Appendices. London: NICE; 2014.
14. Bill and Melinda Gates Foundation Methods for Economic Evaluation Project (MEEP). The Gates Reference Case: What it is, why it’s important, and how to use it. London: NICE; 2014.
15. Culyer AJ. Are there really ten good arguments for a societal perspective in the economic evaluations of medical innovations? In: Culyer AJ, Kobelt G, eds. Portrait of a Health Economist: Festschrift in Honour of Bengt Jönsson. Lund: Institute of Health Economics; 2014: 33-38.
16. Culyer AJ, Bombard Y. An equity framework for health technology assessments. Med Dec Making. 2012; 32: 428-441.
17. Norheim OF, Baltussen R, Johri M, et al. Guidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysis. Cost Eff Resour Alloc. 2014; 12: 18. doi: 10.1186/1478-7547-12-18
18. Johri M, Norheim OF. Can cost-effectiveness analysis integrate concerns for equity? Systematic review. Int J Technol Assess Health Care. 2012; 28(2): 125-132. doi: 10.1017/S0266462312000050
19. Cookson R, Drummond M, Weatherly H. Explicit incorporation of equity considerations into economic evaluation of public health interventions. Health Econ Policy Law. 2009; 4(Pt 2): 231-245. doi: 10.1017/S1744133109004903
20. Wailoo A, Tsuchiya A, McCabe C. Weighting must wait: incorporating equity concerns into cost effectiveness analysis may take longer than expected. Pharmacoeconomics. 2009; 27: 983-989.
21. Epstein DM, Chalabi Z, Claxton K, Sculpher M. Efficiency, equity, and budgetary policies: informing decisions using mathematical programming. Med Dec Making. 2007; 27: 128-137.
22. Baltussen R, Niessen L. Priority setting of health interventions: the need for multi-criteria decision analysis. Cost Eff Res Alloc. 2006; 4: 4.
23. Culyer AJ, Lomas J. Deliberative processes and evidence-informed decision-making in health care-do they work and how might we know? Evidence and Policy. 2006; 2: 357-371. (Reprinted in Cookson R, Claxton K, eds. The Humble Economist: Tony Culyer on Health, Health Care and Social Decision Making. London: Office of Health Economics; 2012: 283-300).
24. Culyer AJ. Deliberative Processes in Decisions about Health Care Technologies: Combining Different Types of Evidence, Values, Algorithms and People. London: Office of Health Economics; 2009.
25. Asaria M, Griffin S, Cookson RA, Whyte S, Tappenden P. Distributional cost-effectiveness analysis of health care programmes: A methodological case study of the UK bowel cancer screening programme. Health Econ. 2015; 24: 742-754.
26. Robson M, Asaria M, Tsuchiya A, Ali S, Cookson R A. Eliciting the level of health inequality aversion in England (CHE Research Paper no. 125). York: Centre for Health Economics, University of York; 2016.
27. Verguet S, Laxminarayan R, Jamison DT. Universal public Finance of tuberculosis treatment in India: an extended cost-effectiveness analysis. Health Econ. 2015; 24: 318-332.
28. Culyer AJ. Equity and Equality, in Henk ten Have ed. International Encyclopaedia in Global Bioethics. Berlin: Springer; 2016. http://link.springer.com/referenceworken¬try/10.1007/978-3-319-05544-2_176-1. Accessed April 8, 2016.
29. Culyer AJ. The bogus conflict between efficiency and equity. Health Econ. 2006; 15: 1155-1158.
30. Culyer AJ, Wagstaff A. Equity and equality in health and health care. J Health Econ. 1993; 12: 431-457. (reprinted in Barr N, ed. Economic Theory and the Welfare State, Cheltenham: Edward Elgar; 2001: 231-257 and in Culyer AJ, ed. Health Economics: Critical Perspectives on the World Economy. London: Routledge; 2006: 483-509).